AMRX vs. AXP
Compare and contrast key facts about Amneal Pharmaceuticals, Inc. (AMRX) and American Express Company (AXP).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMRX or AXP.
Correlation
The correlation between AMRX and AXP is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AMRX vs. AXP - Performance Comparison
Key characteristics
AMRX:
0.19
AXP:
0.67
AMRX:
0.56
AXP:
1.11
AMRX:
1.06
AXP:
1.16
AMRX:
0.08
AXP:
0.73
AMRX:
0.70
AXP:
2.36
AMRX:
9.77%
AXP:
8.92%
AMRX:
35.97%
AXP:
31.68%
AMRX:
-97.52%
AXP:
-83.91%
AMRX:
-85.93%
AXP:
-14.95%
Fundamentals
AMRX:
$3.51B
AXP:
$193.96B
AMRX:
-$0.04
AXP:
$14.31
AMRX:
1.24
AXP:
3.14
AMRX:
86.10
AXP:
6.22
AMRX:
$2.83B
AXP:
$75.33B
AMRX:
$1.04B
AXP:
$62.05B
AMRX:
$511.54M
AXP:
$14.80B
Returns By Period
In the year-to-date period, AMRX achieves a -8.84% return, which is significantly lower than AXP's -6.40% return. Over the past 10 years, AMRX has underperformed AXP with an annualized return of -16.78%, while AXP has yielded a comparatively higher 15.05% annualized return.
AMRX
-8.84%
0.14%
-15.06%
10.91%
15.32%
-16.78%
AXP
-6.40%
17.91%
-5.88%
19.05%
27.05%
15.05%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AMRX vs. AXP — Risk-Adjusted Performance Rank
AMRX
AXP
AMRX vs. AXP - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Amneal Pharmaceuticals, Inc. (AMRX) and American Express Company (AXP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AMRX vs. AXP - Dividend Comparison
AMRX has not paid dividends to shareholders, while AXP's dividend yield for the trailing twelve months is around 1.06%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMRX Amneal Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AXP American Express Company | 1.06% | 0.91% | 1.24% | 1.35% | 1.05% | 1.42% | 1.29% | 1.51% | 1.32% | 1.61% | 1.58% | 1.05% |
Drawdowns
AMRX vs. AXP - Drawdown Comparison
The maximum AMRX drawdown since its inception was -97.52%, which is greater than AXP's maximum drawdown of -83.91%. Use the drawdown chart below to compare losses from any high point for AMRX and AXP. For additional features, visit the drawdowns tool.
Volatility
AMRX vs. AXP - Volatility Comparison
The current volatility for Amneal Pharmaceuticals, Inc. (AMRX) is 14.26%, while American Express Company (AXP) has a volatility of 16.27%. This indicates that AMRX experiences smaller price fluctuations and is considered to be less risky than AXP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AMRX vs. AXP - Financials Comparison
This section allows you to compare key financial metrics between Amneal Pharmaceuticals, Inc. and American Express Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AMRX vs. AXP - Profitability Comparison
AMRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Amneal Pharmaceuticals, Inc. reported a gross profit of 255.89M and revenue of 695.42M. Therefore, the gross margin over that period was 36.8%.
AXP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, American Express Company reported a gross profit of 15.82B and revenue of 18.93B. Therefore, the gross margin over that period was 83.5%.
AMRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Amneal Pharmaceuticals, Inc. reported an operating income of 100.35M and revenue of 695.42M, resulting in an operating margin of 14.4%.
AXP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, American Express Company reported an operating income of 3.33B and revenue of 18.93B, resulting in an operating margin of 17.6%.
AMRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Amneal Pharmaceuticals, Inc. reported a net income of 24.62M and revenue of 695.42M, resulting in a net margin of 3.5%.
AXP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, American Express Company reported a net income of 2.58B and revenue of 18.93B, resulting in a net margin of 13.7%.